Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insulin? * Does it preserve what is left of the body's insulin production? Participants will take either DFMO or a placebo (looks like DFMO but has no active ingredients) two times a day for about 6 months. Participants will have 6 in person visits and 1 phone visit over a period of 12 months. Visits wi
Sponsor: Emily K. Sims
Check if you qualify for this type 1 diabetes clinical trial in Chicago, IL
If you're searching for type 1 diabetes treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.